147 related articles for article (PubMed ID: 2045454)
1. Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.
Makki S; Muret P; Renaud A; Agache P; Magnin P
J Chromatogr; 1991 Feb; 539(2):443-8. PubMed ID: 2045454
[TBL] [Abstract][Full Text] [Related]
2. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.
Muret P; Humbert P; Makki S; Bechtel P; Urien S; Tillement JP
Arch Dermatol Res; 1993; 285(5):287-90. PubMed ID: 8379689
[TBL] [Abstract][Full Text] [Related]
3. Chronopharmacokinetics of 5-methoxypsoralen.
Treffel P; Renaud A; Humbert P; Makki S; Faivre B; Agache PG
Acta Derm Venereol; 1990; 70(6):515-7. PubMed ID: 1981428
[TBL] [Abstract][Full Text] [Related]
4. Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.
Saïd A; Makki S; Muret P; Toubin G; Humbert P; Millet J
Exp Dermatol; 1997 Apr; 6(2):57-63. PubMed ID: 9209885
[TBL] [Abstract][Full Text] [Related]
5. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
Yang XY; Gasparro FP; DeLeo VA; Santella RM
J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
[TBL] [Abstract][Full Text] [Related]
6. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
Saïd A; Makki S; Muret P; Humbert P; Millet J
J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
[TBL] [Abstract][Full Text] [Related]
7. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
[TBL] [Abstract][Full Text] [Related]
8. Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.
Leveque N; Muret P; Mary S; Bérard M; Makki S; Pierre Kantelip J; Humbert P
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):119-27. PubMed ID: 12383487
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 8-methoxypsoralen by high-performance liquid chromatography.
Ketchum CH; Robinson CA; Huang ST
Clin Chem; 1990 Nov; 36(11):1956-7. PubMed ID: 2242576
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic localization of 8-methoxypsoralen in psoriasis skin in vitro.
Bertaux B; Dubertret L; Moreno G
Acta Derm Venereol; 1981; 61(6):481-5. PubMed ID: 6177157
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
12. The binding of 8-methoxypsoralen by human serum albumin.
Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
Farmaco Sci; 1978 Sep; 33(9):667-75. PubMed ID: 744263
[TBL] [Abstract][Full Text] [Related]
13. Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro.
Artuc M; Stuettgen G; Schalla W; Schaefer H; Gazith J
Br J Dermatol; 1979 Dec; 101(6):669-77. PubMed ID: 534612
[TBL] [Abstract][Full Text] [Related]
14. Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.
David M; Lowe NJ; Halder RM; Borok M
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):931-2. PubMed ID: 2254480
[No Abstract] [Full Text] [Related]
15. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
[TBL] [Abstract][Full Text] [Related]
16. Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
Pibouin M; Zini R; Nguyen P; Renouard A; Tillement JP
Br J Dermatol; 1987 Aug; 117(2):207-15. PubMed ID: 3651341
[TBL] [Abstract][Full Text] [Related]
17. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
18. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P
Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684
[TBL] [Abstract][Full Text] [Related]
19. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood.
Shephard SE; Zogg M; Burg G; Panizzon RG
Arch Dermatol Res; 1999 Sep; 291(9):491-9. PubMed ID: 10541879
[TBL] [Abstract][Full Text] [Related]
20. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
